Work

Mitigating Excessive Mitochondrial Fission Through the Development of a Selective Macrocyclic Inhibitor Targeting Fis1/Mid51 Signaling

Year: 2026

Type: article

Source: Journal of Medicinal Chemistry

DOI: 10.1021/acs.jmedchem.6c00333

Authors: Mulate Zerihun, Sayan Chakraborty, Ayetenew Abita, Suchismita Dey, Ivan Lopez, Rani Wainer Shlomo, Mahesh Kumar Cinthakunta Sridhar, Liron Davis, Offir Ertracht, Shaul Atar, Deborah E. Shalev, Marta De Zotti, Bereketeab Haileselassie, Nir Qvit

Institutions: Bar-Ilan University, Stanford Medicine, Stanford University, Western Galilee Hospital, Hebrew University of Jerusalem, Azrieli College of Engineering Jerusalem, University of Padua

Language: English

Topic: Mitochondrial Function and Pathology

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Israel Science Foundation, National Heart, Lung, and Blood Institute, Stanford Maternal and Child Health Research Institute

Awards: Role of Altered Mitochondrial dynamics in Graft Versus Host Disease, G924307579

OpenAlex ID: W7162199027

FWCI:

Cites: 76

Cited by:

Related to: